Analyst firms · BofA Securities · ELV
BofA Securities ELV price target and rating history
Elevance Health Inc. (ELV) · Health Care
BofA Securities rates Elevance Health Inc. (ELV) Buy with a $435 price target, as of its latest action on Apr 29, 2026. It has published 3 rating actions on ELV since September 2022, including 2 upgrades and 1 downgrade. Across 5 firms with a ELV price target in the last 12 months, the median target is $425. BofA Securities's $435 is 2% above that.
- Current rating
- Buy
- Price target
- $435
- Median target, all firms
- $425
- Actions on ELV
- 3
BofA Securities price target on ELV
Every BofA Securities rating on ELV
- Apr 29, 2026
- Jul 18, 2024
- Sep 9, 2022
How other firms rate ELV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Buy | $498 | May 20, 2026 |
| BofA Securities | Buy | $435 | Apr 29, 2026 |
| Evercore ISI | In-line | $345 | Apr 8, 2026 |
| RBC Capital Markets | Sector Perform | $358 | Feb 3, 2026 |
| Wolfe Research | Outperform | $425 | Jan 8, 2026 |
Questions about BofA Securities and ELV
- What is BofA Securities's price target for ELV?
- BofA Securities's latest stated price target for Elevance Health Inc. (ELV) is $435, from its action on Apr 29, 2026.
- What is BofA Securities's rating on ELV?
- BofA Securities rates ELV Buy, a bullish rating, as of Apr 29, 2026.
- When did BofA Securities last change its view on ELV?
- On Apr 29, 2026, BofA Securities upgrades to Buy from Neutral, price target $435.
- How does BofA Securities's ELV target compare with other analysts?
- Across 5 firms with a ELV price target in the last 12 months, the median target is $425. BofA Securities's $435 is 2% above that.
More ELV rating histories
All BofA Securities ratingsELV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.